Mehdi Hamadani

Academic / Other · 2 registered clinical trials.

Status	Trial	Phase	Started
Completed	MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantat Allogeneic Hematopoietic Stem Cell Transplantation	Phase 1 / Phase 2	2014-11-19
Completed	Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation Graft vs Host Disease	Phase 2	2014-01-20